The TJX Companies, Inc.
The TJX Companies, Inc. (TJX) Financial Performance & Income Statement Overview
Explore the financials of The TJX Companies, Inc. (TJX), including yearly and quarterly data on income, cash flow, and balance sheets.
The TJX Companies, Inc. (TJX) Income Statement & Financial Overview
View the income breakdown for The TJX Companies, Inc. TJX across both annual and quarterly reports.
| Metric | Q4 2025 | Q3 2025 | Q2 2025 | Q1 2025 |
|---|---|---|---|---|
| Revenue | $16.35B | $14.06B | $13.47B | $12.48B |
| Cost of Revenue | $11.37B | $9.62B | $9.38B | $8.74B |
| Gross Profit | $4.98B | $4.44B | $4.09B | $3.74B |
| Gross Profit Ratio | $0.30 | $0.32 | $0.30 | $0.30 |
| R&D Expenses | $0.00 | $0.00 | $0.00 | $0.00 |
| SG&A Expenses | $3.13B | $2.75B | $2.67B | $2.40B |
| Operating Expenses | $3.13B | $2.75B | $2.67B | $2.40B |
| Total Costs & Expenses | $14.50B | $12.37B | $12.05B | $11.14B |
| Interest Income | $59.00M | $63.00M | $66.00M | $69.00M |
| Interest Expense | $17.00M | $20.00M | $20.00M | $19.00M |
| Depreciation & Amortization | $309.00M | $266.00M | $265.00M | $264.00M |
| EBITDA | $2.21B | $2.02B | $1.75B | $1.67B |
| EBITDA Ratio | $0.14 | $0.14 | $0.13 | $0.13 |
| Operating Income | $1.85B | $1.69B | $1.42B | $1.34B |
| Operating Income Ratio | $0.11 | $0.12 | $0.11 | $0.11 |
| Other Income/Expenses (Net) | $42.00M | $43.00M | $46.00M | $50.00M |
| Income Before Tax | $1.89B | $1.74B | $1.47B | $1.39B |
| Income Before Tax Ratio | $0.12 | $0.12 | $0.11 | $0.11 |
| Income Tax Expense | $491.00M | $439.00M | $369.00M | $320.00M |
| Net Income | $1.40B | $1.30B | $1.10B | $1.07B |
| Net Income Ratio | $0.09 | $0.09 | $0.08 | $0.09 |
| EPS | $1.23 | $1.15 | $0.97 | $0.94 |
| Diluted EPS | $1.23 | $1.14 | $0.96 | $0.93 |
| Weighted Avg Shares Outstanding | $1.14B | $1.13B | $1.13B | $1.13B |
| Weighted Avg Shares Outstanding (Diluted) | $1.14B | $1.14B | $1.14B | $1.15B |
Over the past four quarters, The TJX Companies, Inc. demonstrated steady revenue growth, increasing from $12.48B in Q1 2025 to $16.35B in Q4 2025. Operating income reached $1.85B in Q4 2025, maintaining a consistent 11% margin over recent quarters. Despite fluctuations in R&D and SG&A expenses, EBITDA remained robust at $2.21B, reflecting operational efficiency. Net income rose to $1.40B, with EPS at $1.23. Disciplined expense management helped sustain profitability, highlighting solid overall financial performance.
Unlock 25+ Years of Financial Data
Get access to extended historical data, advanced metrics, and more with our premium plan